AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Auglimy M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Aush Pharma LLP

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Auglimy M 2mg/500mg Tablet

Diabetam Duo 2mg/500mg tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose. Administer Diabetam Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach including diet, exercise, and weight management as prescribed. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; recognize symptoms like sweating, dizziness, headache, and tremors, and have readily available glucose (e.g., sugary snacks or juice). Alcohol elevates hypoglycemia risk and should be avoided. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment; pregnancy or breastfeeding necessitates prior medical consultation. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential.

Primary Ingredients of Auglimy M 2mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Auglimy M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Auglimy M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Auglimy M 2mg/500mg Tablets should be administered with a meal.

Common Side effects of Auglimy M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Auglimy M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Auglimy M 2mg/500mg Tablet whole; do not crush, chew, or divide it. Administer this medication with food.

How Auglimy M 2mg/500mg Tablet works:

Auglimy M 2mg/500mg tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Auglimy M 2mg/500mg Tablet with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Auglimy M 2mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Administering Auglimy M 2mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Auglimy M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician. Auglimy M 2mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Auglimy M 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in those with severe hepatic dysfunction.

What if you forget to take Auglimy M 2mg/500mg Tablet :

Should you forget to take your Auglimy M 2mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.

Facts to Know About Auglimy M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Auglimy M 2mg/500mg Tablet

Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential consequence of taking Auglimy M 2mg/500mg tablets. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but a significant risk for individuals with impaired kidney function, advanced age, or high alcohol consumption. Characteristic symptoms include muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. The appearance of these symptoms necessitates immediate cessation of Auglimy M 2mg/500mg tablet use and prompt medical attention.
Auglimy M 2mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when coupled with a balanced diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and increases insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Auglimy M 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged use can result in Vitamin B12 deficiency.
Prolonged use of Auglimy M 2mg/500mg tablets can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications, including peripheral neuropathy (tingling and numbness in extremities), weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, proposed by some studies, involve annual supplemental Vitamin B12 intake.
Indeed, taking Auglimy M 2mg/500mg tablets may lead to hypoglycemia (low blood glucose). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Auglimy M 2mg/500mg tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Auglimy M 2mg/500mg Table...
98
MRP 120
18% off